Medical Oncology

Uzm. Dr. Erdoğan Şeyran

Doctor and researcher SBÜ. Van Eğitim ve Araştırma Hastanesi Van
Breast Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • InstitutionSBÜ. Van Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications17 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-5238-0522ORCIDFrom source
  • Last synchronised5 November 2026 10:47https://vaneah.saglik.gov.tr/TR-47354/tibbi-onkoloji.html#erdogan-seyransaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

17 publications

  1. Serum Procalcitonin for the Diagnosis of Spontaneous Bacterial Peritonitis in Patients With Decompensated Cirrhosis: A Prospective Study

    Eurasian Journal of Medical Advances, 2026

    DOI 10.14744/ejma.267011 Open-access full textSource: OpenAlex

  2. Association between gastric epithelial dysplasia and clinicopathological characteristics and overall survival in patients with metastatic gastric adenocarcinoma

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.2013606 Open-access full textSource: ORCID

  3. Development of a Clinicopathological Prognostic Model and Risk Classification to Predict Disease-Free Survival in Patients with Gastric Adenocarcinoma Following Neoadjuvant Chemotherapy and Curative Gastrectomy

    Current Oncology, 2026

    DOI 10.3390/curroncol33090500 PMID 42782847 Open-access full textSource: ORCID

  4. Association of ABO and Rh blood groups with survival and clinicopathological characteristics in patients with gastric adenocarcinoma: a single-center retrospective study

    Journal of Current Hematology & Oncology Research, 2026

    DOI 10.51271/jchor-0090 Open-access full textSource: ORCID

  5. Integrating molecular and clinical determinants of survival in a real-world glioblastoma cohort

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.1850445 Open-access full textSource: ORCID

  6. Beyond IMDC: do expanded models improve survival discrimination in metastatic renal cell carcinoma? A real-world cohort study

    Frontiers in Oncology, 2026

    DOI 10.3389/fonc.2026.1887870 PMID 42597456 Open-access full textSource: ORCID

  7. Pathological Complete Response and Residual Disease Patterns After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Clinical and Laboratory Associations

    Cancers, 2026

    DOI 10.3390/cancers18182983 PMID 42794949 Open-access full textSource: ORCID

  8. Prognostic Factors in Upper Gastrointestinal Neuroendocrine Carcinoma: A Retrospective Cohort Study of Clinicopathological Features and Survival Outcomes

    Cancer Management and Research, 2026

    DOI 10.2147/cmar.s618644 PMID 42483270 Open-access full textSource: ORCID

  9. Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer

    Journal of Oncology Pharmacy Practice, 2026

    DOI 10.1177/10781552231156521 PMID 36760158 11 citations (OpenAlex) Source: ORCID

  10. Association of Tumor Distribution Pattern with Stage at Diagnosis and Presentation Pattern in Patients with Invasive Breast Cancer

    Bagcilar Medical Bulletin, 2026

    DOI 10.4274/bmb.galenos.2026.16046 Open-access full textSource: OpenAlex

View all 17 publications